These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 483859)

  • 1. Metabolism of budralazine, a new antihypertensive agent, III.
    Ono K; Saito T; Sasano H; Moroi R; Sano M; Akimoto T
    Xenobiotica; 1979 Apr; 9(4):227-36. PubMed ID: 483859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 2nd communication: A single oral administration of [14C]nipradilol to spontaneously hypertensive rats.
    Kimata H; Kabuto S; Yonemitsu M; Koide T; Nakao H; Suzuki J
    Arzneimittelforschung; 1985; 35(11):1680-4. PubMed ID: 4091870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
    Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive and general pharmacological properties of budralazine.
    Chiba T; Shibamura S; Tanaka M; Yamasaki T; Hashimoto H; Kurebayashi Y; Kasai Y; Ryokawa Y; Tamura K; Hirohashi M; Akashi A
    Arzneimittelforschung; 1981; 31(7):1080-7. PubMed ID: 7023495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.
    Shibamura S; Chiba T; Suzuki I; Akashi A
    Arzneimittelforschung; 1981; 31(7):1076-9. PubMed ID: 6268123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.
    Kitagawa H; Esumi Y; Kurosawa S; Sekine S; Yokoshima T
    Xenobiotica; 1979 Jul; 9(7):415-28. PubMed ID: 40350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution and excretion in urine, feces and respiratory CO2 of [14C]-ciclosidomine in beagle dogs.
    Matteo MR; Zavorskas P; Esber H
    Arzneimittelforschung; 1985; 35(1A):329-32. PubMed ID: 3921036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of budralazine, a new antihypertensive drug.
    Akashi A; Chiba T; Suzuki I; Hashimoto H
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):134-46. PubMed ID: 736687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution, metabolism and excretion of [14C]ebastine after repeated oral administration in rats.
    Fujii T; Tanaka K; Matsumoto S; Hatoyama T; Nomura N; Tagawa M; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):538-43. PubMed ID: 7912072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotensive and cardiovascular action of budralazine in unanesthetized and unrestrained dogs.
    Konno K; Nonaka K; Ueno A
    Arzneimittelforschung; 1981; 31(7):1072-5. PubMed ID: 7196755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of [14C]-amezinium metilsulfate in rats.
    Nambu K; Yoshida K; Kagemoto A; Matsumoto K; Miyazaki H; Hashimoto M; Esumi Y; Jin Y; Gunji S; Iwabuchi M
    Arzneimittelforschung; 1988 Jul; 38(7):909-18. PubMed ID: 3207436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 1st communication: Metabolism and disposition after single oral administration of [14C]nipradilol.
    Kabuto S; Kimata H; Yonemitsu M; Koide T; Nakao H; Suzuki J
    Arzneimittelforschung; 1985; 35(11):1674-9. PubMed ID: 3937533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, distribution, metabolism and excretion of 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(o-difluoromethoxyphenyl)- 1,4-dihydropyridine (PP-1466) in rats.
    Inoue Y; Nakayama K; Wachi M; Kumakura K; Matsumoto T; Iwamoto M; Motoyoshi Y; Aikawa K
    Arzneimittelforschung; 1985; 35(5):813-8. PubMed ID: 4026905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.